UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Stock Option (right to buy) | Â (1)(2) | 01/30/2022 | Common Stock | 1,750 | $ 36.36 | D | Â |
Stock Option (right to buy) | Â (1)(2) | 04/30/2022 | Common Stock | 5,624 | $ 36.47 | D | Â |
Stock Option (right to buy) | Â (1)(2) | 10/31/2022 | Common Stock | 5,626 | $ 36.68 | D | Â |
Stock Option (right to buy) | Â (1)(2) | 12/17/2022 | Common Stock | 9,000 | $ 40.22 | D | Â |
Stock Option (right to buy) | Â (1)(2) | 01/28/2023 | Common Stock | 1,408 | $ 49.48 | D | Â |
Stock Option (right to buy) | Â (1)(2) | 01/28/2023 | Common Stock | 4,218 | $ 49.48 | D | Â |
Stock Option (right to buy) | Â (1)(2) | 04/29/2023 | Common Stock | 3,238 | $ 59.24 | D | Â |
Stock Option (right to buy) | Â (1)(2) | 04/29/2023 | Common Stock | 512 | $ 59.24 | D | Â |
Stock Option (right to buy) | Â (1)(2) | 07/29/2023 | Common Stock | 3,750 | $ 71.33 | D | Â |
Stock Option (right to buy) | Â (1)(2) | 10/28/2023 | Common Stock | 3,750 | $ 78.12 | D | Â |
Stock Option (right to buy) | Â (1)(2) | 12/02/2023 | Common Stock | 4,000 | $ 81.56 | D | Â |
Stock Option (right to buy) | Â (1)(2) | 02/03/2024 | Common Stock | 2,812 | $ 74.3 | D | Â |
Stock Option (right to buy) | Â (1)(2) | 02/03/2024 | Common Stock | 938 | $ 74.3 | D | Â |
Stock Option (right to buy) | Â (2)(3) | 07/28/2024 | Common Stock | 7,155 | $ 87.64 | D | Â |
Stock Option (right to buy) | Â (2)(4) | 07/28/2024 | Common Stock | 345 | $ 84.64 | D | Â |
Stock Option (right to buy) | Â (2)(5) | 10/27/2024 | Common stock | 3,750 | $ 103.1 | D | Â |
Stock Option (right to buy) | Â (2)(6) | 12/19/2024 | Common Stock | 5,000 | $ 117.18 | D | Â |
Stock Option (right to buy) | Â (2)(7) | 02/02/2025 | Common Stock | 2,907 | $ 118.57 | D | Â |
Stock Option (right to buy) | Â (2)(8) | 02/02/2025 | Common Stock | 843 | $ 118.57 | D | Â |
Stock Option (right to buy) | Â (2)(9) | 05/04/2025 | Common Stock | 5,000 | $ 109.9 | D | Â |
Stock Option (right to buy) | Â (2)(10) | 07/27/2025 | Common Stock | 5,000 | $ 132.56 | D | Â |
Stock Option (right to buy) | Â (2)(11) | 11/09/2025 | Common Stock | 5,000 | $ 114.08 | D | Â |
Stock Option (right to buy) | Â (2)(12) | 02/01/2026 | Common Stock | 4,008 | $ 100.8 | D | Â |
Stock Option (right to buy) | Â (2)(13) | 02/01/2026 | Common Stock | 992 | $ 100.8 | D | Â |
Stock Option (right to buy) | Â (2)(14) | 05/02/2026 | Common Stock | 3,125 | $ 104.97 | D | Â |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
AHMED NADIM C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT, NJ 07901 |
 |  |  Pres., Hematology and Oncology |  |
/s/ Nadim Ahmed | 06/13/2018 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | The option is immediately exercisable and fully vested. |
(2) | The option was issued pursuant to the Company's 2017 Stock Incentive Plan. |
(3) | The option is immediately exercisable and will vest as follows: 1,875 shares on July 28, 2015 (VESTED); 1,875 shares on July 28, 2016 (VESTED); 1,875 shares on July 28, 2017 (VESTED); and 1,530 shares on July 28, 2018. |
(4) | The option is immediately exercisable and will fully vest on July 28, 2018. |
(5) | The option is immediately exercisable and will vest as follows: 937 shares on October 27, 2015 (VESTED); 937 shares on October 27, 2016 (VESTED); 938 shares on October 27, 2017 (VESTED); and 938 shares on October 27, 2018. |
(6) | The option is immediately exercisable and will vest as follows: 1,250 shares on December 19, 2015 (VESTED); 1,250 shares on December 19, 2016 (VESTED); 1,250 shares on December 19, 2017 (VESTED); and 1,250 shares on December 19, 2018. |
(7) | The option is immediately exercisable and will vest as follows: 937 shares on February 2, 2016 (VESTED); 937 shares on February 2, 2017 (VESTED); 937 shares on February 2, 2018 (VESTED); and 95 shares on February 2, 2019. |
(8) | The option is immediately exercisable and will fully vest on February 2, 2019. |
(9) | The option is immediately exercisable and will vest as follows: 1,250 shares on May 4, 2016 (VESTED); 1,250 shares on May 4, 2017 (VESTED); 1,250 shares on May 4, 2018 (VESTED); and 1,250 shares on May 4, 2019. |
(10) | The option is immediately exercisable and will vest as follows: 1,250 shares on July 27, 2016 (VESTED); 1,250 shares on July 27, 2017 (VESTED); 1,250 shares on July 27, 2018; and 1,250 shares on July 27, 2019. |
(11) | The option is immediately exercisable and will vest as follows: 1,250 shares on November 9, 2016 (VESTED); 1,250 shares on November 9, 2017 (VESTED); 1,250 shares on November 9, 2018; and 1,250 shares on November 9, 2019. |
(12) | The option is immediately exercisable and will vest as follows: 1,250 shares on February 1, 2017 (VESTED); 1,250 shares on February 1, 2018 (VESTED); 1,250 shares on February 1, 2019; and 258 shares on February 1, 2020. |
(13) | The option is immediately exercisable and will fully vest on February 1, 2020. |
(14) | The option is immediately exercisable and will vest as follows: 781 shares on May 2, 2017 (VESTED); 781 shares on May 2, 2018 (VESTED); 781 shares on May 2, 2019; and 782 shares on May 2, 2020. |